Acetylcholine receptor-α subunit expression in myasthenia gravis: A role for the autoantigen in pathogenesis?

Muscle and Nerve

Volumn 40, Issue 2, 2009, Pages 279-286

  Jian, Rong Sheng ^a,b   Liang, Cheng Li ^a,b   Prabhakar, Bellur S ^b   Meriggioli, Matthew N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Acetylcholine receptor; Acetylcholine receptor subunit; Experimental autoimmune myasthenia gravis; Myasthenia gravis

Indexed keywords

ALPHA BUNGAROTOXIN; AUTOANTIGEN; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ALPHA; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNOGLOBULIN DEPOSITION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; ANTIBODIES; BUNGAROTOXINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREUND'S ADJUVANT; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; PROTEIN BINDING; RECEPTORS, CHOLINERGIC; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TORPEDO;

EID: 67749118219     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21371     Document Type: Article

References (25)

1. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2002;2:797-804.
2. Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present and future. J Clin Invest 2006;116:2843-2854. (Pubitemid 44684466)
3. Asher O, Neumann D, Fuchs S. Increased levels of acetylcholine receptor α-subunit mRNA in experimental autoimmune myasthenia gravis. FEBS Lett 1988;233: 277-281. (Pubitemid 18158994)
4. Asher OD, Neumann D, Witzemann V, Fuchs S. Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis. FEBS Lett 1990;267:231-235. (Pubitemid 20216696)
5. Guyon T, Levasseur P, Truffault F, Cottin C, Gaud C, Berrih- Aknin S. Regulation of acetylcholine receptor α subunit variants in human myasthenia gravis. J Clin Invest 1994;94: 16-24.
6. Guyon T, Wakkach A, Poea S, Mouly V, Klingel-Schmitt I, Levaseur P, Beeson D, et al. Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. J Clin Invest 1998;102:249-263.
7. Christadoss P, Poussin M, Deng C. Animal models of myasthenia gravis. Clin Immunol 2000;94:75-87.
8. Wu B, Goluszko E, Christadoss P. Experimental autoimmune myasthenia gravis in the mouse. In: Coligan JE, Shevach EM, Strober W, editors. Current protocols of immunology. Vol.3. New York: John Wiley & Sons; 1997. p. 8.1-8.16.
9. Sheng JR, Li L, Ganesh BB, Prabhakar BS, Meriggioli MN. Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia. Clin Immunol 2008;128:172-180.
10. Sheng JR, Li LC, Ganesh BB, Vasu C, Prabhakar BS, Meriggioli MN. Suppression of experimental autoimmune myasthenia gravis (EAMG) by granulocyte-macrophage colonystimulating factor (GM-CSF) is associated with an expansion of FoxP3+ regulatory T cells. J Immunol 2006;177:5296-5306. (Pubitemid 44527602)
11. Engel AE, Santa T. Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann NY Acad Sci 1971;183: 46-63.
12. Beeson D, Morris A, Vincent A, Newsom-Davis J. The human muscle nicotinic acetylcholine receptor a-subunit exists as two isoforms: a novel exon. EMBO J 1990;9:2101-2106. (Pubitemid 20198952)
13. Newland CF, Beeson D, Vincent A, Newsom-Davis J. Functional and non-functional isoforms of the human acetylcholine receptor. J Physiol 1995;489:767-778. (Pubitemid 26015847)
14. DeBaets M, Stassen MH. The role of antibodies in myasthenia gravis. J Neurol Sci 2002;202:5-11.
15. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 1976;26:1054-1059.
16. Hoedemaekers A, Bessereau JL, Graus Y, Guyon T, Changeux JP, Berrih-Aknin S, et al. Role of the target organ in determining susceptibility to experimental myasthenia gravis. J Neuroimmunol 1998;89:131-141. (Pubitemid 28389585)
17. Bever CT Jr, Chang HW, Penn AS, Jaffe IA, Bock E. Penicillamine-induced myasthenia gravis. Effects of penicillamine on acetylcholine receptor. Neurology 1982;32:1077-1082.
18. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated disease: implications for immunotherapy. Nat Rev Immunol 2002;2:85-95.
19. Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, et al. Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice. J Clin Invest 2002;109:1111-1120. (Pubitemid 34408586)
20. Morris A, Beeson D, Jacobson L, Baggi F, Vincent A, Newsom-Davis J. Two isoforms of the muscle acetylcholine receptor alpha-subunit are translated in the human cell line TE671. FEBS Lett 1991;295:116-118.
21. Saini SS, Tuzun E, Christadoss P. The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit. J Neuroimmunol 2005;169:177-179. (Pubitemid 41527103)
22. Talib S, Okarma TB, Lebkowski JS. Differential expression of human nicotinic acetylcholine receptor alpha subunit variants in muscle and non-muscle tissues. Nucleic Acids Res 1993;21;233-237. (Pubitemid 23151892)
23. Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008;41:123-132.
24. Notkins AL, Onodera T, Prabhakar BS. Virus-induced autoimmunity. In: Notkins AL, Oldstone MBA, editors. Concepts in viral pathogenesis. New York: Springer; 1984. p. 210-215.
25. Suber TL, Casciola-Rosen L, Rosen A. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis. Nat Clin Pract Rheumatol 2008;4:201-209.